This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (538) mHealth for Data Collection and Research (955)

Published on in Vol 7, No 10 (2018): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9396, first published .
Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled Trial

Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled Trial

Using Mobile Technology (pMOTAR) to Assess Reactogenicity: Protocol for a Pilot Randomized Controlled Trial

Authors of this article:

Kathryn Therese Mngadi1, 2 Author Orcid Image ;   Bhavna Maharaj1 Author Orcid Image ;   Yajna Duki1, 2 Author Orcid Image ;   Douglas Grove3 Author Orcid Image ;   Jessica Andriesen3 Author Orcid Image
Article Authors Cited by (4) Tweetations (2) Metrics

Kathryn Therese Mngadi   1, 2 , MPhil, MBChB ;   Bhavna Maharaj   1 , MPharm ;   Yajna Duki   1, 2 , MMedSc ;   Douglas Grove   3 , MS ;   Jessica Andriesen   3 , PhD

1 Centre for the AIDS Programme of Research in South Africa, Durban, South Africa

2 Clinical Research Department, The Aurum Institute, Johannesburg, South Africa

3 Fred Hutchinson Cancer Research Center, Seattle, WA, United States

Corresponding Author:

  • Kathryn Therese Mngadi, MPhil, MBChB
  • Clinical Research Department
  • The Aurum Institute
  • The Ridge, Aurum House
  • 29 Queens Road, Parktown
  • Johannesburg, 1693
  • South Africa
  • Phone: 27 0825744541
  • Email: kmngadi@auruminstitute.org